Prenetics Global Limited (PRENW)
NASDAQ: PRENW
· Real-Time Price · USD
0.01
0.00 (19.05%)
At close: May 07, 2025, 1:56 PM
0.01
0.00%
After-hours: May 07, 2025, 04:00 PM EDT
Company Description
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company.
Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test.
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem.
Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Limited

Country | HK |
IPO Date | n/a |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 320 |
CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 701-706, K11 Atelier King’s Road Quarry Bay, HK | |
Website | https://www.prenetics.com |
Stock Details
Ticker Symbol | PRENW |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001876431 |
CUSIP Number | G72245114 |
ISIN Number | KYG722451146 |
Employer ID | 00-0000000 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Samantha Kwok | Chief of Staff to Group Chief Executive Officer & Vice President of People & Operations |
Sheng Wu Yeung | Co-Founder, Chairperson & Chief Executive Officer |
Hoi Chun Lo | Chief Financial Officer |
David Eric Vanderveen | Director & President of Americas |
Dr. Chi Hung Tzang Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Senthil Kumar Sundaram M.D. | Chief Clinical Officer |
Joel Neoh | Chief Consumer Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 07, 2025 | S-8 | Filing |
Apr 30, 2025 | 20-F | Filing |
Mar 05, 2025 | 6-K | Filing |
Dec 13, 2024 | 6-K | Filing |
Nov 27, 2024 | 6-K | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | SCHEDULE 13G/A | [Amend] Filing |
Oct 15, 2024 | 6-K | Filing |
Oct 07, 2024 | 6-K | Filing |
Sep 27, 2024 | 6-K | Filing |